Bal Pharma share news and announcements
NSE: BALPHARMABSE: 524824Pharmaceuticals & BiotechnologySmall Cap
Last close ₹81.09down ₹3.48 (4.11%)BSE ₹81.60
Share price at the NSE close on 23 Oct 2026. Previous close ₹84.57.
52-week range of traded prices to 23 Oct 2026
₹60.00Low, 30 Mar 2026₹124.60High, 10 Sep 2026
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹129 Cr2,779th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- 17.9
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- 1.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.48%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 9.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 9.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.94
- Volume, NSEVolume. Shares traded on the last trading day.
- 18,242
Bal Pharma dividends
17 filed, newest first.
May 2025
May 2024
29 May · Dividend
28 May · Dividend
Sep 2023
May 2023
May 2022
Jun 2021
May 2019
May 2018
May 2017
May 2016
May 2015
30 May · Dividend
Board of Directors of the Company at its meeting held on May 29, 2015 has recommended a dividend of Re. 1/- per Equity Share of Rs. 10 each i.e 10% on the paid up equity share capital of the Company, for the financial year ended March 31, 2015.
May 2014
29 May · Dividend
Board of Directors of the Company at its meeting held on May 28, 2014 has recommended payment of dividend of Re. 1/- (10%) per Equity Share of Rs. 10 each.
May 2013
28 May · Dividend
Board of Directors of the Company at its meeting held on May 27, 2013 has recommended payment of dividend of Re.0.75/- (7.5%) per equity share of Rs.10 each.
Jun 2009
29 Jun · Dividend
Board of Directors, at its meeting held on June 29, 2009 has recommended Dividend of Rs.0.75 per equity share of Rs.10 each.
Jun 2008
24 Jun · Dividend
Board of Directors of the Company at its meeting held on June 23, 2008 has recommended Dividend of 10% per share as against 7.5 % in the previous year.
Jul 2007
2 Jul · Dividend
Board of Directors at their meeting held on June 30, 2007 has recommended a Dividend of Rs.7.5% per share.